Roche details Columvi OS data in quest for expanded lymphoma approval

Roche re­leased de­tailed da­ta at the Eu­ro­pean Hema­tol­ogy As­so­ci­a­tion con­gress for its CD20xCD3 bis­pe­cif­ic an­ti­body Columvi in ear­li­er lines of large B cell lym­phoma, show­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.